Whole-exome and targeted gene sequencing of large-cell lung carcinoma reveals recurrent mutations in the PI3K pathway

Schwendenwein A, Megyesfalvi Z, Barany N, Valko Z, Bugyik E, Lang C, et al. Molecular profiles of small cell lung cancer subtypes: therapeutic implications. Mol Ther Oncolytics. 2021;20:470–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu SH, Hsu KW, Lai YL, Lin YF, Chen FH, Peng PH, et al. Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma. Mol Ther Nucleic Acids. 2021;25:1–10.

Article  PubMed  PubMed Central  Google Scholar 

Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17:362–87.

Article  PubMed  Google Scholar 

Lin G, Qi K, Liu B, Liu H, Li J. A nomogram prognostic model for large cell lung cancer: analysis from the Surveillance, Epidemiology and End Results Database. Transl Lung Cancer Res. 2021;10:622–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sugár S, Bugyi F, Tóth G, Pápay J, Kovalszky I, Tornóczky T, et al. Proteomic analysis of lung cancer types-a pilot study. Cancers. 2022;14:2629.

Article  PubMed  PubMed Central  Google Scholar 

Ramos-Paradas J, Gómez-Sánchez D, Rosado A, Ucero AC, Ferrer I, García-Luján R, et al. Comprehensive characterization of human lung large cell carcinoma identifies transcriptomic signatures with potential implications in response to immunotherapy. J Clin Med. 2022;11:1500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karlsson A, Brunnström H, Micke P, Veerla S, Mattsson J, La Fleur L, et al. Gene expression profiling of large cell lung cancer links transcriptional phenotypes to the new histological WHO 2015 classification. J Thorac Oncol. 2017;12:1257–67.

Article  PubMed  Google Scholar 

Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

do Valle ÍF, Giampieri E, Simonetti G, Padella A, Manfrini M, Ferrari A, et al. Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data. BMC Bioinforma. 2016;17:341.

Article  Google Scholar 

Ye K, Schulz MH, Long Q, Apweiler R, Ning Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics. 2009;25:2865–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cingolani P. Variant annotation and functional prediction: SnpEff. Methods Mol Biol. 2022;2493:289–314.

Article  CAS  PubMed  Google Scholar 

Flanagan SE, Patch AM, Ellard S. Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomark. 2010;14:533–7.

Article  CAS  Google Scholar 

Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC. SIFT missense predictions for genomes. Nat Protoc. 2016;11:1–9.

Article  CAS  PubMed  Google Scholar 

Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, et al. Comprehensive characterization of cancer driver genes and mutations. Cell. 2018;173:371–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian X, Gu T, Lee MH, Dong Z. Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer. Biochim Biophys Acta Rev Cancer. 2022;1877:188645.

Article  CAS  PubMed  Google Scholar 

Yu N, Hwang M, Lee Y, Song BR, Kang EH, Sim H, et al. Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer. J Exp Clin Cancer Res. 2023;42:37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Ren Z, Yu B, Tang J. Development of nomogram based on immune-related gene FGFR4 for advanced non-small cell lung cancer patients with sensitivity to immune checkpoint inhibitors. J Transl Med. 2021;19:22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao G, Cui L, Zhou F, Jiang T, Wang W, Mao S, et al. Special issue “The advance of solid tumor research in China”: FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer. Int J Cancer. 2023;152:79–89.

Article  CAS  PubMed  Google Scholar 

Zhou C, Li S, Bin K, Qin G, Pan P, Ren D, et al. ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer. Cancer Lett. 2022;547:215855.

Article  CAS  PubMed  Google Scholar 

Wang J, Wren JD, Ding Y, Chen J, Mittal N, Xu C, et al. EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer. Cancer Lett. 2022;536:215641.

Article  CAS  PubMed  Google Scholar 

Mei S, Xu Q, Hu Y, Tang R, Feng J, Zhou Y, et al. Integrin β3-PKM2 pathway-mediated aerobic glycolysis contributes to mechanical ventilation-induced pulmonary fibrosis. Theranostics. 2022;12:6057–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif